Sodré, M.T.C.; Ferraz, F.A.; Alencar, A.K.V.; Silva, K.F.; Silva, D.H.d.S.; Silva, L.d.S.; Araújo Carneiro, J.S.d.S.; Monteiro, C.A.; Silva, L.C.N.; Monteiro, A.d.S.
The Potential of Lactiplantibacillus plantarum ATCC 14917 in the Development of Alginate-Based Gel Formulations with Anti–Staphylococcus aureus Properties. Pharmaceuticals 2023, 16, 1112.
https://doi.org/10.3390/ph16081112
AMA Style
Sodré MTC, Ferraz FA, Alencar AKV, Silva KF, Silva DHdS, Silva LdS, Araújo Carneiro JSdS, Monteiro CA, Silva LCN, Monteiro AdS.
The Potential of Lactiplantibacillus plantarum ATCC 14917 in the Development of Alginate-Based Gel Formulations with Anti–Staphylococcus aureus Properties. Pharmaceuticals. 2023; 16(8):1112.
https://doi.org/10.3390/ph16081112
Chicago/Turabian Style
Sodré, Monaliza Teresa Campos, Fernanda Avelino Ferraz, Amanda Karoline Vieira Alencar, Karinny Farias Silva, Douglas Henrique dos Santos Silva, Lucas dos Santos Silva, Jéssica Silva dos Santos Araújo Carneiro, Cristina Andrade Monteiro, Luis Cláudio Nascimento Silva, and Andrea de Souza Monteiro.
2023. "The Potential of Lactiplantibacillus plantarum ATCC 14917 in the Development of Alginate-Based Gel Formulations with Anti–Staphylococcus aureus Properties" Pharmaceuticals 16, no. 8: 1112.
https://doi.org/10.3390/ph16081112
APA Style
Sodré, M. T. C., Ferraz, F. A., Alencar, A. K. V., Silva, K. F., Silva, D. H. d. S., Silva, L. d. S., Araújo Carneiro, J. S. d. S., Monteiro, C. A., Silva, L. C. N., & Monteiro, A. d. S.
(2023). The Potential of Lactiplantibacillus plantarum ATCC 14917 in the Development of Alginate-Based Gel Formulations with Anti–Staphylococcus aureus Properties. Pharmaceuticals, 16(8), 1112.
https://doi.org/10.3390/ph16081112
